temoporfin has been researched along with Necrosis in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (39.13) | 18.2507 |
2000's | 10 (43.48) | 29.6817 |
2010's | 3 (13.04) | 24.3611 |
2020's | 1 (4.35) | 2.80 |
Authors | Studies |
---|---|
Chandrashekar, TK; Cherukommu, S; Jose, J; Karunakaran, SC; Madhuri, B; Marydasan, B; Ramaiah, D; Rao, CM; Rao, KS; Viji, M | 1 |
Chen, ZL; Gadoora, MA; Gao, YH; Li, MY; Meharban, F; Nyokong, T; Sajjad, F; Wang, JH; Yan, YJ | 1 |
Axelsson, J; Hansson, K; Höglund, OV; Lagerstedt, AS; Södersten, F; Swartling, J | 1 |
Bezdetnaya, L; Bressenot, A; Foster, TH; Garrier, J; Gräfe, S; Guillemin, F; Marchal, S; Mitra, S | 1 |
Conde, R; Fontolliet, C; Monnier, P; Radu, A; Van den Bergh, H; Wagnieres, G | 1 |
Eljamel, MS | 1 |
Fedier, A; Fink, D; Haller, U; Heinzelmann-Schwarz, V; Hornung, R; Walt, H | 1 |
Karamanolis, G; Karvouni, E; Kostopanagiotou, G; Ladas, S; Macropoulou, M; Mallas, E; Raptis, SA; Serafetinidis, AA; Zissis, M | 1 |
Bezdetnaya, L; D'Hallewin, MA; Fadloun, A; Guillemin, F; Marchal, S; Maugain, E | 1 |
Bown, SG; Emberton, M; Freeman, A; Lees, WR; Moore, CM; Mosse, CA; Nathan, TR | 1 |
Altermatt, HJ; Krueger, T; Opitz, I; Pan, Y; Ris, HB; Wagnières, G | 1 |
Altermatt, HJ; Andrejevic-Blant, S; Ballini, JP; Borle, F; Cheng, C; Krueger, T; Pan, Y; Ris, HB; Tran, N; Yan, H | 1 |
Ayaru, L; Bown, SG; Macrobert, AJ; Novelli, M; Pereira, SP; Wittmann, J | 1 |
Bown, SG; Buonaccorsi, G; Chang, SC; MacRobert, A | 1 |
Altermatt, HJ; Althaus, U; Bonnett, R; Lim, CK; Nachbur, B; Ris, HB; Stewart, CM; Wang, Q | 1 |
Bown, SG; Davies, CL; MacRobert, AJ; Messman, H; Mikvy, P; Pauer, M; Sams, VR; Stewart, JC | 1 |
Braichotte, D; Fontolliet, C; Grosjean, P; Monnier, P; Savary, JF; van den Bergh, H; Wagnieres, G | 1 |
Altermatt, HJ; Althaus, U; Krueger, T; Li, Q; Lim, CK; Reynolds, B; Ris, HB | 1 |
Andrejevic-Blant, S; Fontolliet, C; Monnier, P; van den Bergh, H; Wagnieres, G; Woodtli, A | 1 |
Crompton, NE; Haller, U; Hornung, R; Jentsch, B; Keefe, KA; Köchli, OR; Perewusnyk, G; Walt, H | 1 |
Bown, SG; Buonaccorsi, GA; Fielding, DI; Hanby, AM; Hetzel, MR; MacRobert, AJ | 1 |
Dobler-Girdziunaite, D; Fink, D; Haller, U; Hornung, R; Stallmach, T; Walt, H | 1 |
de Jode, ML; Grahn, MF; Rovers, JP | 1 |
1 review(s) available for temoporfin and Necrosis
Article | Year |
---|---|
New light on the brain: The role of photosensitizing agents and laser light in the management of invasive intracranial tumors.
Topics: Aminolevulinic Acid; Brain Neoplasms; Clinical Trials as Topic; Dihematoporphyrin Ether; Glioma; Humans; Lasers; Mesoporphyrins; Necrosis; Photochemotherapy; Photosensitizing Agents; Prognosis | 2003 |
2 trial(s) available for temoporfin and Necrosis
Article | Year |
---|---|
Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer.
Topics: Aged; Biopsy; Fibrosis; Humans; Magnetic Resonance Imaging; Male; Mesoporphyrins; Middle Aged; Necrosis; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Treatment Outcome | 2006 |
Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies.
Topics: Antineoplastic Agents; Brachial Plexus; Combined Modality Therapy; Dose-Response Relationship, Drug; Feasibility Studies; Humans; Infarction; Intraoperative Care; Mesoporphyrins; Mesothelioma; Necrosis; Neoplasm Invasiveness; Peripheral Nervous System Neoplasms; Photochemotherapy; Radiation-Sensitizing Agents; Skin; Thoracic Neoplasms; Thoracotomy; Thrombosis | 1996 |
20 other study(ies) available for temoporfin and Necrosis
Article | Year |
---|---|
In Vitro and In Vivo Demonstration of Human-Ovarian-Cancer Necrosis through a Water-Soluble and Near-Infrared-Absorbing Chlorin.
Topics: Biological Transport; Female; Humans; Infrared Rays; Necrosis; Ovarian Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins; Solubility; Water | 2018 |
Synthesis and pharmacological evaluation of chlorin derivatives for photodynamic therapy of cholangiocarcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Cell Line, Tumor; Cholangiocarcinoma; Female; Humans; Light; Male; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Necrosis; Photochemotherapy; Photosensitizing Agents; Porphyrins; Xenograft Model Antitumor Assays | 2020 |
Online dosimetry for temoporfin-mediated interstitial photodynamic therapy using the canine prostate as model.
Topics: Animals; Dogs; Dose-Response Relationship, Radiation; Male; Mesoporphyrins; Necrosis; Photochemotherapy; Photosensitizing Agents; Prostate; Radiotherapy, Computer-Assisted | 2016 |
Compartmental targeting for mTHPC-based photodynamic treatment in vivo: Correlation of efficiency, pharmacokinetics, and regional distribution of apoptosis.
Topics: Animals; Apoptosis; Caspase 3; Collagen Type IV; Female; Immunohistochemistry; Mesoporphyrins; Mice; Mice, Inbred BALB C; Necrosis; Neoplasm Proteins; Neoplasms; Photochemotherapy; Photosensitizing Agents; Tissue Distribution; Xenograft Model Antitumor Assays | 2010 |
Mucosal ablation with photodynamic therapy in the esophagus: optimization of light dosimetry in the sheep model.
Topics: Animals; Esophagus; Mesoporphyrins; Mucous Membrane; Necrosis; Photochemotherapy; Photosensitizing Agents; Radiation Dosage; Sheep | 2003 |
Role of p53 and ATM in photodynamic therapy-induced apoptosis.
Topics: Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line; DNA-Binding Proteins; Fibroblasts; Gene Deletion; Genes, p53; Mesoporphyrins; Mice; Mice, Knockout; Necrosis; Photochemotherapy; Protein Serine-Threonine Kinases; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Suppressor Proteins | 2003 |
Photodynamic therapy in normal pig stomach: protective effect of octreotide.
Topics: Animals; Gastric Mucosa; Gastrointestinal Agents; Lasers; Mesoporphyrins; Models, Animal; Necrosis; Octreotide; Photochemotherapy; Photosensitizing Agents; Protective Agents; Random Allocation; Regional Blood Flow; Stomach; Swine | 2004 |
Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids.
Topics: Apoptosis; Blotting, Western; Caspase 3; Caspases; Cell Death; Cell Survival; Colonic Neoplasms; Cytochromes c; Dose-Response Relationship, Drug; Enzyme Activation; Flow Cytometry; HT29 Cells; Humans; Kinetics; Membrane Potentials; Mesoporphyrins; Mitochondria; Necrosis; Photochemotherapy; Photosensitizing Agents; Spheroids, Cellular | 2005 |
Preclinical comparison of mTHPC and verteporfin for intracavitary photodynamic therapy of malignant pleural mesothelioma.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Mesoporphyrins; Mesothelioma; Mice; Necrosis; Photochemotherapy; Photosensitizing Agents; Pleural Neoplasms; Porphyrins; Rats; Rats, Inbred F344; Survival Rate; Verteporfin | 2006 |
Correlation of photodynamic activity and fluorescence signaling for free and pegylated mTHPC in mesothelioma xenografts.
Topics: Animals; Female; Mesoporphyrins; Mesothelioma; Mice; Mice, Nude; Microscopy, Fluorescence; Necrosis; Neoplasm Transplantation; Photochemotherapy; Photosensitizing Agents; Pleural Neoplasms; Transplantation, Heterologous | 2007 |
Photodynamic therapy using verteporfin photosensitization in the pancreas and surrounding tissues in the Syrian golden hamster.
Topics: Animals; Colon; Cricetinae; Duodenum; Female; Injections, Intravenous; Liver; Mesocricetus; Mesoporphyrins; Necrosis; Pancreas; Photochemotherapy; Photosensitizing Agents; Porphyrins; Verteporfin | 2007 |
Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin.
Topics: Animals; Antineoplastic Agents; Dogs; Male; Mesoporphyrins; Necrosis; Photochemotherapy; Prostate; Prostatic Neoplasms; Radiation-Sensitizing Agents; Spectrometry, Fluorescence; Tissue Distribution; Ultrasonography; Urethra | 1996 |
Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC).
Topics: Animals; Cricetinae; Female; Mesocricetus; Mesoporphyrins; Microscopy, Fluorescence; Necrosis; Pancreas; Pancreatic Neoplasms; Photochemotherapy; Photosensitizing Agents | 1997 |
Photodynamic therapy of early squamous cell carcinomas of the esophagus: a review of 31 cases.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Dihematoporphyrin Ether; Esophageal Neoplasms; Esophagus; Female; Hematoporphyrin Derivative; Hematoporphyrin Photoradiation; Humans; Male; Mesoporphyrins; Middle Aged; Necrosis; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Photosensitizing Agents; Precancerous Conditions; Treatment Outcome | 1998 |
Photosensitizing effects of m-tetrahydroxyphenylchlorin on human tumor xenografts: correlation with sensitizer uptake, tumor doubling time and tumor histology.
Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Female; Humans; Mesoporphyrins; Mesothelioma; Mice; Mice, Nude; Necrosis; Neoplasm Transplantation; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Transplantation, Heterologous | 1998 |
Interstitial photodynamic therapy with tetra(m-hydroxyphenyl)chlorin: tumor versus striated muscle damage.
Topics: Animals; Carcinoma, Squamous Cell; Cricetinae; Male; Mesocricetus; Mesoporphyrins; Microscopy, Fluorescence; Muscle, Skeletal; Necrosis; Photochemotherapy; Photosensitizing Agents; Time Factors | 1998 |
m-THPC-mediated photodynamic therapy (PDT) does not induce resistance to chemotherapy, radiotherapy or PDT on human breast cancer cells in vitro.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Survival; Drug Resistance, Neoplasm; Female; Humans; Mesoporphyrins; Necrosis; Paclitaxel; Photochemotherapy; Photosensitizing Agents; Radiation Tolerance; Radiotherapy; Tumor Cells, Cultured | 1998 |
Fine-needle interstitial photodynamic therapy of the lung parenchyma: photosensitizer distribution and morphologic effects of treatment.
Topics: Animals; Immunohistochemistry; Lung; Mesoporphyrins; Microscopy, Fluorescence; Necrosis; Photochemotherapy; Photosensitizing Agents; Rats; Rats, Wistar; Tissue Distribution | 1999 |
Photodynamic therapy for the hypercalcemic type of the small cell carcinoma of the ovary in a mouse xenograft model.
Topics: Animals; Carcinoma, Small Cell; Female; Humans; Hypercalcemia; Mesoporphyrins; Mice; Mice, Inbred ICR; Mice, Nude; Necrosis; Neoplasm Transplantation; Ovarian Neoplasms; Photochemotherapy; Photosensitizing Agents; Transplantation, Heterologous | 1999 |
Significantly increased lesion size by using the near-infrared photosensitizer 5,10,15,20-tetrakis (m-hydroxyphenyl)bacteriochlorin in interstitial photodynamic therapy of normal rat liver tissue.
Topics: Animals; Dihematoporphyrin Ether; Laser Therapy; Liver; Male; Mesoporphyrins; Necrosis; Photochemotherapy; Photosensitizing Agents; Porphyrins; Random Allocation; Rats; Rats, Wistar | 2000 |